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Materials & Methods 
Chlamydia pneumoniae infection of neuronal cells induces changes in calcium-associated 
 gene expression consistent with Alzheimer’s disease 
Christopher A. Cappellini, Ahmad B. Cader, Keith G. Williams, Juliana D. Zoga, Susan T. Hingley, Brian J. Balin, Denah M. Appelt, Marcus G. Bell 
Center for Chronic Disorders of Aging (CCDA), Philadelphia College of Osteopathic Medicine, Philadelphia, PA 
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Conclusions 
Chlamydia pneumoniae alters several genes and proteins associated with calcium  
signaling in neuronal cells. The disruption of calcium signaling is congruent with 
neurodegeneration as observed in Alzheimer’s disease. 
Introduction 
Results 
 
 
Abstract 
Background and Significance: Previous studies have shown that cells infected with Chlamydia 
pneumoniae (Cpn) exhibit altered gene expression consistent with that observed in Alzheimer’s 
disease (AD). Furthermore, AD neurodegeneration has been linked to dysregulation of 
intracellular calcium and calcium-related processes. Therefore, we hypothesize that one 
mechanism by which pathogenesis evolves in AD is through infection-induced changes in 
expression of calcium-related genes. 
Objectives: To determine if infection of neuronal cells with Cpn alters expression of calcium- 
related genes associated with neurodegeneration. 
Methods: SK-N-MC neuronal cells were infected with Cpn (AR39 strain; MOI=1) for 3 to 72 
hours, then calcium-related genes were screened with real-time PCR microarrays 
(SABiosciences PAHS-066). 
Results: Following infection, approximately 29 genes displayed regulation changes of 2-fold or 
greater, including genes pertaining to neurotransmitters, cell cycle and immune regulators, and 
other calcium-responsive elements. Genes involved in synaptic function and memory such as 
AREG, ATF3, EGR2 and GEM were initially up regulated, then fell to baseline or below by 72 
hours. Many of the affected genes have been implicated in AD pathogenesis. 
Conclusions: Our data suggest that Cpn alters calcium-related gene expression in host 
neurons consistent with calcium dysfunction previously documented in AD. This study may 
elucidate how, in its effort to establish a favorable environment, Cpn could affect cellular 
processes that contribute to AD pathogenesis. 
Heat Map Analysis of 84 Calcium-Related Genes   
     Alzheimer’s disease (AD) is considered to be the most common form of late-life dementia 
affecting memory, cognition, personality, and behavior (1). The cause(s) of AD are thought to 
involve both environmental and genetic factors. There are two main forms of the disease: 
familial or early-onset that typically affects patients below the age of 60 and sporadic or late-
onset affecting those older than 60 years. The presence of a combination of mutated genes, 
coding for apparently abnormally functioning proteins, is a determining factor in early-onset AD 
(1). The specific risk factors/causes of late-onset AD remain to be elucidated, but environmental 
factors including trauma, diet, and infection may play a role.  
     The accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles 
leading to degeneration of specific populations of neurons are the two key histopathological 
entities characterizing AD. Beta-amyloid peptide (Aβ) is derived from the amyloid precursor 
protein (APP) and is a major component of the extracellular deposits in AD brains. One 
mechanism by which Aβ may contribute to the overall pathogenesis of AD is through the 
disruption of calcium homeostasis in neurons. Studies have shown that resting free calcium 
levels are lower in cells from Alzheimer’s patients than in controls (2). Furthermore, alteration in 
calcium signaling has been observed in both sporadic and familial AD (3). 
     Calcium signaling is tightly regulated in time, intensity, and space, and is responsible for a 
variety of neuronal functions. In a healthy neuronal cell, calcium levels are regulated at both the 
gene and protein level. Calcium influx from the extracellular environment modulates calcium 
levels, as do intracellular stores in the endoplasmic reticulum. First proposed by Khachaturian in 
1994, the calcium hypothesis postulates that sustained disturbances of intracellular calcium are 
a leading cause of neurodegenerative disorders (3). 
      Previously, we detected infection with Chlamydia pneumoniae (Cpn) in late-onset AD brains 
(4). This infection was found in glial and neuronal cells, and may initiate specific damage 
resulting in neurodegeneration. In this regard, we hypothesize that calcium homeostasis is 
altered by the presence of Cpn and possibly other pathogens, thereby affecting both acute and 
long-term events. To test this hypothesis, we used RT-PCR to evaluate the regulation of 84 
calcium-related genes in neuronal cells over the duration of 3 to 72hrs following Cpn infection. 
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Gene Symbol Gene Name 
Growth Factors 
AREG Amphiregulin
FGF6 Fibroblast growth factor 6
TNF Tumor necrosis factor
Serum Responsive elements 
CNN1 Calponin 1 
CYR61 Cysteine-rich, angiogenic inducer, 61
EGR1 Early growth response 1
EGR2 Early growth response 2
FOS FBJ murine osteosarcoma viral oncogene homolog
FOSB FBJ murine osteosarcoma viral oncogene homolog B
JUNB Jun B proto-oncogene
NR4A2 Nuclear receptor subfamily 4, group A, member 2
S100A6 S100 calcium binding protein A6
SRF Serum response factor (c-fos serum response element-binding transcription factor)
VCL Vinculin
Gene Symbol Gene Name 
Metabolism 
AHR Aryl hydrocarbon receptor
Signaling 
PPKAR1A Protein kinase, cAMP-dependent, regulatory, type I, alpha
SGK1 Serum/glucocorticoid regulated kinase 1
Immune Regulation 
IL2 Interleukin 2
IL6 Interleukin 6
PTGS2 Prostaglandin-endoperoxide synthase 2
Gene Symbol Gene Name 
Neuropeptides / Neurotransmitters 
CGA Chorionic gonadotropin A
CHGA Chromogranin A
GIPR Gastric inhibitory polypeptide receptor
INHBA Inhibin, beta A
KCNA5 Potassium voltage-gated channel, shaker-related subfamily, member 5
S100A12 S100 calcium binding protein A12
S100G S100 calcium binding protein G
SCG2 Secretogranin II
SLC18A1 Solute carrier family 18 (vesicular monoamine), member 1
SSTR2 Somatostatin receptor 2
VIP Vasoactive intestinal peptide
Gene Symbol Gene Name 
Transcription 
ATF3 Activating transcription factor 3
MAF V-maf musculoaponeurotic fibrosarcoma oncogene homolog
POU1F1 POU class 1 homeobox 1
STAT3 Signal transducer and activator of transcription 3 
Cell Cycle / Cell Survival / DNA Repair 
GEM GTP binding protein overexpressed in skeletal muscle
NF1 Neurofibromin 1
PCNA Proliferating cell nuclear antigen
PMAIP1 Phorbol-12-myristate-13-acetate-induced protein 1
PPP1R15A Protein phosphatase 1, regulatory (inhibitor) subunit 15A
